• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性肺炎:在 III 期非小细胞肺癌患者中采用每日两次放疗同步卡铂和紫杉醇治疗后的结果。

Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer.

机构信息

Department of Radiology, Graduate School of Medicine, Chiba University, Chiba-City, Chiba 260-8670, Japan.

出版信息

Jpn J Clin Oncol. 2010 May;40(5):464-9. doi: 10.1093/jjco/hyp190. Epub 2010 Jan 18.

DOI:10.1093/jjco/hyp190
PMID:20085905
Abstract

OBJECTIVE

To examine the effects of dose-volume factors on the development of radiation pneumonitis in patients with non-small-cell lung cancer who received twice-daily radiotherapy concurrently with carboplatin and paclitaxel chemotherapy.

METHODS

Radiotherapy consisted of twice-daily fractionation of 1.2 Gy, to a total dose of 60 Gy. Weekly carboplatin and paclitaxel were used as a concurrent chemotherapy. Effects of radiotherapy parameters on the development of radiation pneumonitis were retrospectively analyzed.

RESULTS

Fourteen of 37 patients developed Grade 2 or worse (> or = G2) radiation pneumonitis. Grade 2 or worse radiation pneumonitis occurred in all 5 patients with V5 >40%, all 4 patients with V10 >35%, all 4 patients with V13 >32%, 9 of 14 patients with V20 >24% and 8 of 11 patients with V30 >22%, whereas 9 of 32 patients with V5 <40%, 10 of 33 patients with V10 <35%, 10 of 33 patients with V13 <32%, 5 of 23 patients with V20 <24% and 6 of 26 patients with V30 <22%, with respective P values of 0.0045, 0.015, 0.015, 0.015 and 0.008. Eight of 11 patients with a mean lung dose of >14 Gy developed > or = G2 radiation pneumonitis in contrast to 6 of 26 patients with a mean lung dose of <14 Gy (P = 0.008).

CONCLUSIONS

Several cut-off values in the V(dose) and the mean lung dose differentiating probabilities of developing > or = G2 radiation pneumonitis were identified in this combination therapy.

摘要

目的

研究非小细胞肺癌患者接受卡铂和紫杉醇化疗同步每日 2 次放疗时,剂量-体积因素对放射性肺炎发生的影响。

方法

放疗采用 1.2Gy 每日 2 次分割,总剂量 60Gy。每周给予卡铂和紫杉醇同步化疗。回顾性分析放疗参数对放射性肺炎发生的影响。

结果

37 例患者中有 14 例发生 2 级或更高级(>或=G2)放射性肺炎。5 例 V5 >40%、4 例 V10 >35%、4 例 V13 >32%、9 例 V20 >24%和 8 例 V30 >22%的患者均发生 2 级或更高级放射性肺炎,而 V5 <40%、V10 <35%、V13 <32%、V20 <24%和 V30 <22%的患者分别有 9、10、10、5 和 6 例发生 2 级或更高级放射性肺炎(P 值分别为 0.0045、0.015、0.015、0.015 和 0.008)。11 例平均肺剂量>14Gy 的患者中有 8 例发生>或=G2 放射性肺炎,而 26 例平均肺剂量<14Gy 的患者中仅有 6 例发生(P = 0.008)。

结论

在该联合治疗中,V(剂量)和平均肺剂量的几个截断值可区分发生>或=G2 放射性肺炎的概率。

相似文献

1
Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer.放射性肺炎:在 III 期非小细胞肺癌患者中采用每日两次放疗同步卡铂和紫杉醇治疗后的结果。
Jpn J Clin Oncol. 2010 May;40(5):464-9. doi: 10.1093/jjco/hyp190. Epub 2010 Jan 18.
2
[Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].[III期非小细胞肺癌患者先行每周一次紫杉醇诱导化疗,随后进行三维适形放疗并同步每周一次紫杉醇治疗的初步结果]
Ai Zheng. 2006 Oct;25(10):1279-83.
3
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.卡铂/紫杉醇或卡铂/长春瑞滨序贯加速超分割适形放射治疗:卡罗来纳适形治疗联盟一项前瞻性I期剂量递增试验报告
J Clin Oncol. 2004 Nov 1;22(21):4329-40. doi: 10.1200/JCO.2004.02.165.
4
Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.卡铂/紫杉醇诱导治疗后序贯卡铂/紫杉醇同步治疗及剂量递增适形放疗用于治疗局部晚期、不可切除非小细胞肺癌:一项I期试验的初步报告
Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-117-S12-122.
5
Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.放射性肺炎的预测:62例非小细胞肺癌患者三维适形放疗后剂量体积直方图分析
Neoplasma. 2005;52(1):56-62.
6
[Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].每周一次卡铂和紫杉醇联合同步放疗治疗局部晚期非小细胞肺癌的临床研究
Gan To Kagaku Ryoho. 2009 Oct;36(10):1653-6.
7
Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.紫杉醇联合卡铂诱导化疗后序贯紫杉醇同步放疗用于ⅢB期非小细胞肺癌(NSCLC)患者:一项Ⅱ期试验
Lung Cancer. 2007 Nov;58(2):238-45. doi: 10.1016/j.lungcan.2007.06.003. Epub 2007 Jul 20.
8
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.不可切除非小细胞肺癌同步化疗及递增剂量放疗的I期试验结果
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1106-11. doi: 10.1016/j.ijrobp.2006.02.046. Epub 2006 May 26.
9
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.不可切除的局部晚期非小细胞肺癌患者采用诱导性紫杉醇和卡铂治疗后序贯同步放化疗:福克斯蔡斯癌症中心94-001研究报告
Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-89-S12-95.
10
Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.放疗、紫杉醇与卡铂联合治疗局部晚期非小细胞肺癌的疗效
Anticancer Res. 2002 Nov-Dec;22(6B):3429-35.

引用本文的文献

1
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan.度伐利尤单抗同步放化疗中肺炎的剂量-体积关系风险因素:日本多机构研究
Clin Transl Radiat Oncol. 2021 May 29;29:54-59. doi: 10.1016/j.ctro.2021.05.009. eCollection 2021 Jul.
2
Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer.吉西他滨诱导化疗后非小细胞肺癌患者发生 ≥2 级放射性肺炎的危险因素。
Radiat Oncol. 2019 Dec 16;14(1):229. doi: 10.1186/s13014-019-1440-8.
3
Prediction of radiation pneumonitis in lung cancer patients: a systematic review.
预测肺癌患者放射性肺炎:系统综述。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2103-16. doi: 10.1007/s00432-012-1284-1. Epub 2012 Jul 29.